Myth: “Biostimulators are dangerous because they can’t be reversed”
Fact: The lack of reversibility is real but the “dangerous” framing is wrong. Biostimulators have decades of safety data behind them (Sculptra FDA-approved since 2004, Radiesse since 2006). The serious complications (vascular events, granuloma) are rare with proper technique and contraindication screening. The non-reversibility means practitioner choice matters more than with HA, but it doesn’t make the products dangerous per se.
What is honestly true: a poorly-placed Radiesse vascular event has fewer rescue options than a poorly-placed HA event, because hyaluronidase doesn’t work. This raises the importance of practitioner experience and conservative technique, not the danger of the product itself.
Myth: “Biostimulator results are unpredictable”
Fact: Results are gradual, not unpredictable. The biological response to PLLA, CaHA, or PCL is consistent across patients within reasonable bounds. What varies is the magnitude of response — some patients respond more vigorously than others, mostly determined by fibroblast health (age, smoking, sun damage, baseline collagen quality).
What the “unpredictable” perception usually reflects is mismatched expectations. Patients expecting filler-like instant change conclude the biostimulator “didn’t work” at week 2. By month 4, the same patient often says “why didn’t anyone tell me how good this would be.” The treatment is predictable; the timeline is just long.
Myth: “Biostimulators are just expensive long-lasting filler”
Fact: Mechanistically, biostimulators are different products. HA filler is a gel that occupies space until it’s metabolised. Biostimulators are stimuli that trigger your own tissue to produce new collagen. The visible result is biologically different — you’re seeing your own newly-synthesised tissue, not the injected material.
What is honestly true: in everyday use, both look like clear gels in syringes that improve facial appearance. The marketing collapses them together. But the underlying biology is different enough that the indication profiles, results, and trade-offs differ meaningfully. Treating them as interchangeable produces poor outcomes.
Myth: “Biostimulators look more natural than fillers”
Fact: They tend to, but it’s not automatic. The reason biostimulators often look more natural is that the visible improvement is your own tissue, distributed by your own anatomy rather than placed by an injector. Done well, that produces a result that’s indistinguishable from healthy aging.
But poorly-placed biostimulator can look just as artificial as poorly-placed HA. Sculptra over-treated in the mid-face produces a visibly “round” cheek that doesn’t suit the face. Radiesse over-aggressive jawline work produces a visibly “squared” jaw. The naturalness comes from restraint and technique, not the product alone.
Myth: “Sculptra works on the day you get it”
Fact: No — the visible volume on day 1 is the diluent water, not the Sculptra effect. Within 24–72 hours that water absorbs and the face looks essentially like it did before treatment. The real effect from collagen build-up emerges over 4–6 months.
This myth is dangerous because patients who believe it conclude the treatment failed when they look in the mirror on day 3. The honest framing: “Don’t expect to see results for 2–3 months. The day-1 fullness is temporary and not the real outcome.”
Myth: “Biostimulator results are permanent”
Fact: No injectable produces permanent results. Even “permanent” silicone fillers shift and migrate over years. Biostimulator results last 18–36 months for Sculptra, 12–18 months for Radiesse, 1–4 years for Ellanse. Then the new collagen remodels back toward the baseline trajectory.
What is honestly true: biostimulator results are longer than most HA fillers (6–18 months). Maintenance is less frequent. But “permanent” is marketing language — the underlying tissue continues to age, and the result fades with it.
Myth: “Biostimulators are only for older patients”
Fact: Largely true for the heavy biostimulators (Sculptra, Radiesse, Ellanse) — most patients in their 20s and early 30s don’t have meaningful indications. But PN (polynucleotides) and Profhilo can fit younger patients with skin quality concerns or early laxity.
The honest framing: biostimulator value increases with age, peaking in 40s–60s for restoration of significant atrophy. Younger patients are usually better served by HA filler for focal needs and skincare/lifestyle for prevention.
Myth: “All biostimulators are basically the same”
Fact: Sculptra (PLLA), Radiesse (CaHA), Profhilo (HA hybrid), PN (salmon DNA), and Ellanse (PCL) are five quite different products with different mechanisms, indications, and trade-offs. Treating them as interchangeable is a common error — usually because clinics that stock only one product describe it as “the” biostimulator.
The right approach: match the product to the indication. The types compared deep dive walks through how to choose.
FAQ
Are biostimulators worth the cost?
For the right indication, yes. The cost-per-month-of-effect is often similar to or favourable vs HA filler because the longer duration spreads cost. For the wrong indication, no — spending money on biostimulator when filler is the right tool is a waste.
Can biostimulators damage my skin long-term?
No evidence of long-term damage from the products themselves. The risk is short-term (procedural — bruising, swelling) and medium-term (nodules in a small percentage). Patients with decades of biostimulator use have not shown identifiable adverse tissue changes.
Why do some clinics push biostimulators and others avoid them?
Multiple reasons. Some clinics genuinely prefer them. Some have higher profit margins on them. Some lack training in them. The honest answer about any specific clinic’s recommendation requires understanding their reasoning. We use biostimulators where they fit and don’t recommend them where they don’t.
Can I trust marketing claims about specific biostimulator products?
Always healthy to be sceptical. Manufacturer-funded studies tend to be favourable. Look for independent peer-reviewed evidence. Sculptra and Radiesse have the most extensive independent data; newer products have proportionally less. Be wary of specific longevity or efficacy claims without published evidence.
Want a straight answer about biostimulators for your case?
We use Sculptra and Radiesse routinely and discuss honestly when they fit and when they don’t. A short consultation cuts through marketing claims to your specific situation. No commitment.